Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 2/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | PAM | P19021 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17363355 | 0.85 | ADRA2A (0.42) | DGKAMGLLALDH1A1ALOX15TDP1 | |
| SCHEMBL4178740 | 0.80 | ADRA2A (0.34) | DGKAMGLLALOX15TDP1 | |
| SCHEMBL4178735 | 0.80 | ADRA2A (0.34) | DGKAMGLLALOX15TDP1 | |
| SCHEMBL6131136 | 0.80 | LMNA (0.39) | DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1245603 | 0.79 | ADRA2A (0.33) | DGKAALOX15TDP1 | |
| SCHEMBL1245606 | 0.79 | ADRA2A (0.33) | DGKAALOX15TDP1 | |
| SCHEMBL5930841 | 0.78 | CYP2D6 (0.35) | — | |
| SCHEMBL1686031 | 0.77 | EP300 (0.45) | GPR84FFAR1FFAR4FNTAFNTB | |
| SCHEMBL22607802 | 0.77 | EP300 (0.45) | GPR84FFAR1FFAR4FNTAFNTB | |
| SCHEMBL9069525 | 0.77 | EP300 (0.45) | GPR84FFAR1FFAR4FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399569-B2 | Reactive urethane compound having ether bond, curable composition, and cured material | SHOWA DENKO K.K. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20100160557-A1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION, AND CURED MATERIAL | SHOWA DENKO K.K. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-7579066-B2 | Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use | SHOWA DENKO K.K. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-20070218305-A1 | Photosensitive Resin Composition, Cured Product Thereof and Production Method of Printed Circuit Board Using the Same | SHOWA DENKO K.K. (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160557-A1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION, AND CURED MATERIAL | UNC119, MLLT1, H1-0 | DGKA 3836/4885MGLL 4187/4885DNM1 4480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.